Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Thomas Urup

Angiotensinogen and HLA Class II Predict Bevacizumab Response in Recurrent Glioblastoma Patients

Molecular Oncology

Cancer Research

Molecular Medicine

English

Related publications

HLA Class II Haplotypes Predict Favorable Outcomes for Patients With Metastatic RCC

English

HLA Class II Polymorphisms and Susceptibility to Recurrent Respiratory Papillomatosis

Journal of Virology

English

HLA Class-I and Class-Ii Restricted Neoantigen Loads Predict Overall Survival in Breast Cancer

English

Sustained Focal Antitumor Activity of Bevacizumab in Recurrent Glioblastoma

English

Addition of Lomustine for Bevacizumab-Refractory Recurrent Glioblastoma

Acta Oncologica

Nuclear Medicine

English

Bevacizumab and Chemotherapy for Recurrent Glioblastoma: A Single-Institution Experience

English

Single-Institution Retrospective Review of Patients With Recurrent Glioblastoma Treated With Bevacizumab in Clinical Practice

Health Science Reports

English

Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients With Recurrent Glioblastoma in Spain

Value in Health

Occupational Health

English

Bevacizumab and Fotemustine for Recurrent Glioblastoma: A Phase II Study of AINO (Italian Association of Neuro-Oncology)

Journal of Neuro-Oncology

Cancer Research

English